Overcoming the challenges encountered in CAR-T therapy: latest updates from the 2023 ASH annual conference
Chimeric antigen receptor (CAR) -T cell therapy has entered the breakthrough era, characterized by a blend of therapeutic opportunities and challenges. With the integration of genome-editing technology, CAR-T cells will be empowered to become super war…